Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Other Non-Current Assets (2016 - 2022)

Historic Other Non-Current Assets for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2022 value amounting to $427000.0.

  • Aptevo Therapeutics' Other Non-Current Assets fell 4276.14% to $427000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $427000.0, marking a year-over-year decrease of 4276.14%. This contributed to the annual value of $1.3 million for FY2021, which is 5072.41% down from last year.
  • Aptevo Therapeutics' Other Non-Current Assets amounted to $427000.0 in Q3 2022, which was down 4276.14% from $546000.0 recorded in Q2 2022.
  • Aptevo Therapeutics' 5-year Other Non-Current Assets high stood at $12.4 million for Q2 2018, and its period low was $427000.0 during Q3 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $1.3 million (2021), whereas its average is $3.6 million.
  • As far as peak fluctuations go, Aptevo Therapeutics' Other Non-Current Assets soared by 301175.0% in 2018, and later tumbled by 8997.35% in 2019.
  • Over the past 5 years, Aptevo Therapeutics' Other Non-Current Assets (Quarter) stood at $7.4 million in 2018, then increased by 0.67% to $7.5 million in 2019, then plummeted by 65.92% to $2.6 million in 2020, then plummeted by 50.72% to $1.3 million in 2021, then crashed by 66.08% to $427000.0 in 2022.
  • Its Other Non-Current Assets stands at $427000.0 for Q3 2022, versus $546000.0 for Q2 2022 and $1.3 million for Q1 2022.